Bayer issues pile up as blood thinner drug trial fails
Bayer issues pile up as blood thinner drug trial fails. The company’s shares plummeted 16.4% to a 12-year low. The drug was anticipated to generate annual sales exceeding 5 billion euros. Bayer, Germany’s pharmaceutical giant, has terminated a significant late-stage trial for its new anti-clotting drug due to insufficient efficacy, casting uncertainty over its most … Read more